So now we get a label to script out amphetamines in mass to treat patients with binge-eating disorder. Okay, so I’m not a physician, but is hunger the trigger for binge-eating? We were not invited to coordinate the trial for this indication, but I’m betting many people, all of the sudden, had a Dx of BED. I’m all for innovation and novel meds to treat disorders, but some of these approvals are just mystifying. Whatever the case, way to go for Shire Shareholders as the stock totally recovers from the recent Gap Down.
SMZ
